Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1990 1
1992 1
1993 1
1994 2
1995 11
1996 6
1997 6
1998 3
1999 4
2000 1
2003 2
2004 1
2005 1
2006 4
2007 1
2008 4
2009 5
2011 2
2012 6
2013 2
2014 4
2015 3
2016 3
2018 4
2019 2
2020 2
2022 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Randomized trial of TAS-102 for refractory metastatic colorectal cancer.
Mayer RJ, Van Cutsem E, Falcone A, Yoshino T, Garcia-Carbonero R, Mizunuma N, Yamazaki K, Shimada Y, Tabernero J, Komatsu Y, Sobrero A, Boucher E, Peeters M, Tran B, Lenz HJ, Zaniboni A, Hochster H, Cleary JM, Prenen H, Benedetti F, Mizuguchi H, Makris L, Ito M, Ohtsu A; RECOURSE Study Group. Mayer RJ, et al. N Engl J Med. 2015 May 14;372(20):1909-19. doi: 10.1056/NEJMoa1414325. N Engl J Med. 2015. PMID: 25970050 Free article. Clinical Trial.
Immunotherapy in surgical oncology.
Reynolds IS, Fennelly D. Reynolds IS, et al. Among authors: fennelly d. Br J Surg. 2022 Dec 13;110(1):3-5. doi: 10.1093/bjs/znac385. Br J Surg. 2022. PMID: 36349796 No abstract available.
Tumour budding as a prognostic biomarker in biopsies and resections of neoadjuvant-treated rectal adenocarcinoma.
Aherne S, Donnelly M, Ryan ÉJ, Davey MG, Creavin B, McGrath E, McCarthy A, Geraghty R, Gibbons D, Nagtegaal I, Lugli A, Kirsch R, Martin ST, Winter DC, Sheahan K; collaborators at the Centre for Colorectal Disease and International Tumour Budding Consortium funded by the Dutch Cancer Society. Aherne S, et al. Histopathology. 2024 Aug;85(2):224-243. doi: 10.1111/his.15192. Epub 2024 Apr 17. Histopathology. 2024. PMID: 38629323
Common critical pathways in embryogenesis and cancer.
Kelleher FC, Fennelly D, Rafferty M. Kelleher FC, et al. Among authors: fennelly d. Acta Oncol. 2006;45(4):375-88. doi: 10.1080/02841860600602946. Acta Oncol. 2006. PMID: 16760173 Review.
High-intensity chemotherapy with hematopoietic support in breast cancer.
Crown J, Vahdat L, Fennelly D, Francis P, Wasserheit C, Hudis C, Kritz A, Schneider J, Hamilton N, Gilewski T, et al. Crown J, et al. Among authors: fennelly d. Ann N Y Acad Sci. 1993 Nov 30;698:378-88. doi: 10.1111/j.1749-6632.1993.tb17230.x. Ann N Y Acad Sci. 1993. PMID: 7506505 Review.
Characterising the prognostic potential of HLA-DR during colorectal cancer development.
Dunne MR, Phelan JJ, Michielsen AJ, Maguire AA, Dunne C, Martin P, Noonan S, Tosetto M, Geraghty R, Fennelly D, Sheahan K, Ryan EJ, O'Sullivan J. Dunne MR, et al. Among authors: fennelly d. Cancer Immunol Immunother. 2020 Aug;69(8):1577-1588. doi: 10.1007/s00262-020-02571-2. Epub 2020 Apr 18. Cancer Immunol Immunother. 2020. PMID: 32306077 Free PMC article.
79 results